LifeStance Health GroupLFST -0.54%56 Net Cash per Share is $-1.22 as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.26 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 152 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 657894.08% on this metric.
The historical rank and industry rank for LifeStance Health Group's Net Cash per Share or its related term are showing as below:
LFST's Price-to-Net-Cash is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 7.96 * Ranked among companies with meaningful Price-to-Net-Cash only.
LifeStance Health Group (NAS:LFST) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
LifeStance Health Group Net Cash per Share Related Terms
LifeStance Health Group Net Cash per Share Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LFST vs CON, BKD, OPCH: Net Cash per Share Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Price-to-Net-Cash vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Price-to-Net-Cash falls into.
LifeStance Health Group Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
LifeStance Health Group's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Net Cash per Share of $-1.22 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #999999 out of 152 companies in the Healthcare Providers & Services industry.
Is LifeStance Health Group's Net Cash per Share too high?
LifeStance Health Group's current Net Cash per Share is $-1.22. Based on the distribution chart, LifeStance Health Group ranks #999999 out of 152 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Net Cash per Share compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #999999 out of 152 companies for Net Cash per Share. This places LifeStance Health Group in the lower half of its industry. The industry median Net Cash per Share is 7.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Healthcare Providers & Services company?
The median Net Cash per Share among Healthcare Providers & Services companies is 7.96, based on 152 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Net Cash per Share is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Net Cash per Share is $-1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.26, compared to a current price of $10.93 — trading 32.3% above its estimated fair value. The current Net Cash per Share is $-1.22. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Net Cash per Share is $-1.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.93 is trading 32.3% above its estimated GF Value™ of $8.26.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Net Cash per Share: $-1.22
GF Value™: $8.26 vs. price of $10.93 (32.3% above fair value)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
